

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 326.35 |
| Log P | RDKit | 3.41 |
| Topological polar surface area (Å2) | RDKit | 75.99 |
| Number of hydrogen bond acceptors | RDKit | 5 |
| Number of hydrogen bond donors | RDKit | 2 |
| Number of carbon atoms | RDKit | 19 |
| Number of heavy atoms | RDKit | 24 |
| Number of heteroatoms | RDKit | 5 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 0 |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 17 |
| Number of sp3 hybridized carbon atoms | RDKit | 2 |
| Shape complexity | RDKit | 0.11 |
| Number of rotatable bonds | RDKit | 6 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 0 |
| Number of aromatic carbocycles | RDKit | 2 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 2 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Good |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.795674 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Moderately soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -5.91 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 1 |
| CYP1A2 inhibitor | SwissADME | Yes |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | Yes |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | Yes |
| P-glycoprotein substrate | SwissADME | No |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000707 | ENSG00000117594 | HSD11B1 | 3290 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000499 | ENSG00000108839 | ALOX12 | 239 | ChEMBL, NPASS |
| TAR_EXP_000500 | ENSG00000275565 | ALOX5 | 240 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001568 | ENSG00000168610 | STAT3 | 6774 | ChEMBL, NPASS |
| TAR_EXP_000276 | ENSG00000272532 | CYP2D6 | 1565 | ChEMBL, NPASS |
| TAR_EXP_000263 | ENSG00000140505 | CYP1A2 | 1544 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000407 | ENSG00000117525 | F3 | 2152 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000708 | ENSG00000176387 | HSD11B2 | 3291 | ChEMBL, NPASS |
| TAR_EXP_001647 | ENSG00000077498 | TYR | 7299 | BindingDB, NPASS |
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | ChEMBL, NPASS |
| TAR_EXP_001362 | ENSG00000173039 | RELA | 5970 | ChEMBL, NPASS |
| TAR_EXP_000969 | ENSG00000077150 | NFKB2 | 4791 | ChEMBL |
| TAR_EXP_000968 | ENSG00000109320 | NFKB1 | 4790 | ChEMBL |
| TAR_EXP_001235 | ENSG00000107643 | MAPK8 | 5599 | ChEMBL |